Jillian Pintye

Nurse, Scientist, and Associate Professor at the University of Washington in Seattle.
Views are my own. She/Her.

[NIH Women's Health @NIH_ORWH]

📢 Calling all researchers! ORWH, @NIH_OAR, & @NIH partners are highlighting the urgent need for intersectional HIV research focused on women, girls, & gender-diverse populations. Read more about this NOSI here: https://t.co/s25dIuuLHy #HIVresearch #WomensHealth

[NIH Women's Health @NIH_ORWH]

In coordination with the White House Initiative on Women’s Health Research, @NIH issued a NOSI to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women or are female specific. https://t.co/mxSEsujgQy

[WHO Botswana @WHOBotswana]

The National Emergency Medical Team strengthens Basic Emergency Care skills and knowledge to ensure readiness to respond effectively to #emergencies and safeguard communities across #Botswana.

#HealthForAll

[NIH Women's Health @NIH_ORWH]

📢Calling all researchers! ORWH and several @NIH institutes and centers have issued a NOSI to highlight interest in receiving research applications focused on diseases & health conditions that predominantly affect women or are female specific.
For more: https://t.co/mxSEsujOG6

[Implementation Science at the Univ of Washington @ImpSciUW]

📢 📆 Save the date! The 2024 UW #impsci Summer Institute in Global Health will be held August 19-23 in Seattle, Washington. Scan the QR code in the video or visit https://t.co/VmfaCYWDBt to learn more. Registration opens later this month! #implementationscience #implsci

[IMPAACT Network @IMPAACTNetwork]

On this 35th anniversary of #WorldAIDSDay, we honor the lives of those lost to HIV/AIDS and uplift the resilient and collaborative spirit of all engaged in pursuing an end to the global epidemic: https://t.co/S6gXSQllt9

[Botswana Harvard Health Partnership @AidsHarvard]

The Botswana Harvard Health Partnership is proud to launch the groundbreaking Tshireletso Study. This is a hybrid implementation/safety study of long-acting cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) to prevent HIV infection in a post-partum cohort in Botswana
#BHP

[Alison Footman, PhD, MPH @AlisonFootman]

TOMORROW! Learn about STI vaccines, diagnostics, and advocacy efforts in East and Southern Africa! Register at: https://t.co/AId7JbR6z3 and https://t.co/wo9eKiNo1F

[CARTA @CARTAfrica]

#DYK: Over 70% of global cervical cancer cases are caused by high-risk human papillomavirus (HR-HPV) infections? A recent study led by CARTA fellow, @jimkangethe explores the implications for #Kenyan women living with HIV.

Access here: https://t.co/h5Opzucz3a

[Ong'era Mogaka @themogaka]

Our review paper on the challenges and solutions to STI control in the era of HIV and STI prophylaxis has been published.
Find it here. https://t.co/O6zDJephiF
@drjenellstewart
@SpringerCurRpts @KEMRI_Kenya

[IAPAC @IAPAC]

ALERT: @IAPAC renames its annual series of Adherence conferences to #Continuum. While #HIV prevention and treatment adherence will still feature, program will cover more linkage, engagement, re-engagement content and research. #Continuum2024

[Preeclampsia Foundation @preeclampsia]

Today is #WorldHeartDay. Women who have had #preeclampsia have 3-4 x the risk of high blood pressure and 2x risk for heart disease & stroke.

Learn how you can take care of your heart after preeclampsia here: https://t.co/7j8OxKZh7O

[IAS - the International AIDS Society @iasociety]

Researchers at @UW developed a long-acting injectable form of the widely used #HIV antiretroviral combination TLD (tenofovir disoproxil fumarate, lamivudine & dolutegravir). This innovation could improve adherence to HIV treatment.

Read more in @aidsmap: https://t.co/CsKzldZTCZ

[IAS - the International AIDS Society @iasociety]

.@GileadSciences' Kathryn Kersey 🇺🇸 outlines the two current trials on lenacapavir (LEN). It is a subcutaneous injection meaning that it could be a self-injection. The trials are looking at the efficacy of LEN as an injectable every 6-months. #IAS2023

[UNAIDS Global @UNAIDS]

"Women and girls are not being reached sufficiently. The #AIDSUpdate2023 report shows that every week 4,000 adolescent girls & young women are infected with HIV and the majority are in the region of Sub-Saharan Africa."
@_dinotshe, Co-Chair of the Global #HIV Prevention Coalition

[lyndastranixchibanda @Stranchi2]

Join us at the #HIV & #Pediatrics workshop as delegates from all over join together to talk about children and HIV 🇿🇼@Academic_MedEdu @iasociety @IMPAACTNetwork @HelpEndHIV

[IMPAACT Network @IMPAACTNetwork]

Manuscript published for IMPAACT 2010/VESTED!

Safety and efficacy data during pregnancy and up to 50 weeks postpartum support the current recommendation of dolutegravir-based ART, rather than others, when started in pregnancy.

Read more: https://t.co/VWZ9uWuFEw